Viewing Study NCT03069703

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:35 PM
Ignite Modification Date: 2026-05-27 @ 3:09 PM
Study NCT ID: NCT03069703
Status: COMPLETED
Last Update Posted: 2025-11-20
First Post: 2017-02-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
Sponsor: Assistance Publique - Hôpitaux de Paris
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Invasive Pneumococcal Infection View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaccine View
None ANCA- associated vasculitides View
None pneumovax View
None prevenar View
None pneumovas View